top of page

jumbo phages have unique
biological properties of high
potential to develop novel
technologies targeting top priority AMR pathogens

News & PRess

jumbo_kinzbio.png
jumbo_kinzbio.png
jumbo_kinzbio.png
jumbo_kinzbio.png
jumbo_kinzbio.png
jumbo_kinzbio.png

> SEP '24

phage therapy

Pioneering Solutions for Antibiotic-Resistant Infections

Kinzbio was recently featured in an article by BBC News, highlighting the company's significant advancements in the development and successful application of phage therapy in Uruguay.

 

Dr. Gaye from the Ministry of Public Health of Uruguay emphasized the "excellent potential" of this innovative therapy to address the growing challenge of antimicrobial resistance in the country and throughout the region.

image00001 (1).jpeg
Swiss-knife-Victorinox-Work-Champ-21-fun

unleashing the potential of
Jumbo phages
together

Kinzbio fosters collaborations and partnerships with pharma leaders, clinical organizations, academic labs and funding agencies to help the company to accelerate the development of its jumbo phage platform and pipeline.

Kinzbio has an open communication channel with and is always seeking to hear from industry partners and funding institutions interested in joining efforts to keep developing applications based on the biology of jumbo phages.
 

BE IN

TOUCH

Please fill your contact details below:

Thanks for contact us!

Phage technologies for a

healthier world

Microbiome_edited.png

ANtimicrobial
resistance is one
of the major global
health issues that
humanity is facing

every year millions
of lives are lost and
billions are spent in
prevention and
treatment of AMR

phages are natural
bacterial killers
that can be used to
combat AMR pathogens

3305040.png
3305040.png
c1ece665a7319e22602d0d90426d3be5_edited_
3305040.png
3305040.png
3305040.png
News
Partnering
Contact
bottom of page